Skip to main content

Table 2 Toxicities (n = 54 patients). (toxicities shown as worst episode per therapy)

From: Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study

Toxicity

WHO grade

 

I

II

III

IV

Nausea/Vomiting

1 (1.8%)

13 (24.1%)

1 (1.9%)

-

Neutropenia

-

4 (7.4%)

14 (25.9%)

5 (9.3%)

Thrombocytopenia

-

5 (9.3%)

2 (3.7%)

-

Anaemia

18 (33.3%)

7 (13%)

6 (11.1%)

-

Diarrhoea

-

4 (7.4%)

-

-

Stomatitis

-

2 (3.7%)

2 (3.7%)

-

Polyneuropathia

1 (1.8%)

2 (3.7%)

-

-

Hand-Foot-Syndrom

3 (5.6%)

10 (18.1%)

3 (5.6%)

-

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us